TegoScience Inc. (KOSDAQ: 191420)
15,840
+150 (0.96%)
Sep 11, 2024, 9:14 AM KST
TegoScience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Net Income | 3,352 | -2,323 | 264.51 | 139.26 | 1,831 | 855.58 | Upgrade
|
Depreciation & Amortization | 539.7 | 547.11 | 581.39 | 588.71 | 597.22 | 590.35 | Upgrade
|
Loss (Gain) From Sale of Assets | -4,807 | 0 | 0 | - | -1,426 | -1.99 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 1,142 | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -30.91 | -116.5 | 34.16 | 20.81 | 28.45 | -238.5 | Upgrade
|
Loss (Gain) on Equity Investments | 1,192 | 1,231 | 545.28 | 64.23 | 1,116 | - | Upgrade
|
Stock-Based Compensation | 154.35 | 189.64 | 64.81 | - | - | 34.87 | Upgrade
|
Provision & Write-off of Bad Debts | 169.41 | 72.42 | -20.14 | 104.48 | -7.21 | 1.27 | Upgrade
|
Other Operating Activities | -923.03 | -1,017 | -712.86 | -700.22 | 21.8 | -487.86 | Upgrade
|
Change in Accounts Receivable | -309.53 | -261.41 | 864.69 | -371.93 | -1,303 | 5.25 | Upgrade
|
Change in Inventory | 159.47 | 118.31 | -519.04 | 67.6 | 157.06 | -594.09 | Upgrade
|
Change in Accounts Payable | -26.35 | -23.49 | 33.63 | -7.2 | 5.43 | -6.67 | Upgrade
|
Change in Other Net Operating Assets | -165.91 | -354.85 | -96.11 | 551.52 | 259.47 | -116.81 | Upgrade
|
Operating Cash Flow | -695.75 | -794.61 | 1,040 | 457.25 | 1,280 | 41.4 | Upgrade
|
Operating Cash Flow Growth | - | - | 127.52% | -64.27% | 2990.58% | -95.03% | Upgrade
|
Capital Expenditures | -6.34 | -36.13 | -15.47 | -16.19 | -65.18 | -60.18 | Upgrade
|
Sale of Property, Plant & Equipment | 7,494 | 274.75 | - | - | 1,968 | 2 | Upgrade
|
Sale (Purchase) of Intangibles | -834.97 | -1,854 | -420.08 | -207.3 | -232.88 | -73.88 | Upgrade
|
Investment in Securities | -6,463 | 2,737 | -3,008 | -999.19 | -3,292 | -200 | Upgrade
|
Other Investing Activities | 672.01 | 843.15 | 479.78 | 234.5 | 357.17 | 366.27 | Upgrade
|
Investing Cash Flow | 886.97 | 1,996 | -2,990 | -965.88 | -1,259 | 76.39 | Upgrade
|
Short-Term Debt Issued | - | 350 | 100 | 1,000 | - | - | Upgrade
|
Total Debt Issued | 250 | 350 | 100 | 1,000 | - | - | Upgrade
|
Short-Term Debt Repaid | - | -100 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -51.53 | -37.2 | -39.63 | -38.47 | -26.26 | Upgrade
|
Total Debt Repaid | -365.39 | -151.53 | -37.2 | -39.63 | -38.47 | -26.26 | Upgrade
|
Net Debt Issued (Repaid) | -115.39 | 198.47 | 62.8 | 960.37 | -38.47 | -26.26 | Upgrade
|
Issuance of Common Stock | - | - | - | 552.45 | - | 261.61 | Upgrade
|
Other Financing Activities | -94.09 | -41.9 | 85.15 | -6.8 | - | 19.1 | Upgrade
|
Financing Cash Flow | -209.47 | 156.57 | 147.95 | 1,506 | -38.47 | 254.45 | Upgrade
|
Foreign Exchange Rate Adjustments | -42.67 | -51.47 | - | - | - | - | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | 0 | -0 | - | - | Upgrade
|
Net Cash Flow | -60.93 | 1,307 | -1,802 | 997.39 | -18.38 | 372.25 | Upgrade
|
Free Cash Flow | -702.1 | -830.74 | 1,025 | 441.05 | 1,214 | -18.77 | Upgrade
|
Free Cash Flow Growth | - | - | 132.37% | -63.68% | - | - | Upgrade
|
Free Cash Flow Margin | -10.07% | -10.69% | 13.35% | 5.31% | 13.82% | -0.30% | Upgrade
|
Free Cash Flow Per Share | -87.76 | -103.76 | 127.97 | 54.83 | 150.74 | -2.32 | Upgrade
|
Cash Interest Paid | 59.05 | 46.69 | 25.32 | 6.8 | - | - | Upgrade
|
Cash Income Tax Paid | - | 66.49 | 108.71 | 408.79 | -71.49 | 199.79 | Upgrade
|
Levered Free Cash Flow | -1,434 | -2,484 | 396.93 | 243.67 | 964.41 | -129.82 | Upgrade
|
Unlevered Free Cash Flow | -1,385 | -2,445 | 419.1 | 254 | 970.29 | -125.42 | Upgrade
|
Change in Net Working Capital | 143.86 | 468.17 | -97.99 | 49.96 | 276.88 | 797.93 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.